Apyx Medical (APYX) Profit After Tax Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Apyx Medical | 174.53 Mn | 143.65 Mn | 7.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.53% |
| Dec 31, 2025 | 4.13% |
| Sep 30, 2025 | 11.88% |
| Jun 30, 2025 | 4.44% |
| Mar 31, 2025 | -16.42% |
| Dec 31, 2024 | 3.43% |
| Sep 30, 2024 | -1.57% |
| Jun 30, 2024 | -8.93% |
| Mar 31, 2024 | -6.24% |
| Dec 31, 2023 | -19.73% |
| Sep 30, 2023 | -32.54% |
| Jun 30, 2023 | 19.09% |
| Mar 31, 2023 | -30.45% |
| Dec 31, 2022 | -48.60% |
| Sep 30, 2022 | -36.01% |
| Jun 30, 2022 | -32.92% |
| Mar 31, 2022 | -28.78% |
| Dec 31, 2021 | 24.42% |
| Sep 30, 2021 | -34.34% |
| Jun 30, 2021 | -50.79% |
| Mar 31, 2021 | -20.31% |
| Dec 31, 2020 | -1.66% |
| Sep 30, 2020 | -18.66% |
| Jun 30, 2020 | -25.66% |
| Mar 31, 2020 | -17.37% |
| Dec 31, 2019 | 0.08% |
| Sep 30, 2019 | -7.99% |
| Jun 30, 2019 | -172.44% |
| Mar 31, 2019 | 10.58% |
| Dec 31, 2018 | 5.26% |
| Sep 30, 2018 | -27.37% |
| Jun 30, 2018 | -21.30% |
| Mar 31, 2018 | -17.98% |
| Dec 31, 2017 | -37.37% |
| Sep 30, 2017 | -181.85% |
| Jun 30, 2017 | -60.36% |
| Mar 31, 2017 | -61.57% |
| Dec 31, 2016 | -56.15% |
| Sep 30, 2016 | -76.89% |
| Jun 30, 2016 | -26.27% |
| Mar 31, 2016 | -42.86% |
| Dec 31, 2015 | -0.59% |